RISK FACTORS OF ISCHEMIC STROKE IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION
Abstract
To reveal hemostatic, hemodynamic, and genetic indices associated with a high risk of ischemic stroke in patients with chronic atrial fibrillation, 103 patients with coronary artery disease and chronic AF (60 men, 43 women) aged 60.4±4.5 years were examined.
About the Authors
Yu. V. Shchukin
ГБОУ ВПО СамГМУ Минздравсоцразвития России
Russian Federation
Russian Federation
A. O. Rubanenko
ГБОУ ВПО СамГМУ Минздравсоцразвития России
Russian Federation
Russian Federation
A. V. Germanov
ГБОУ ВПО СамГМУ Минздравсоцразвития России
Russian Federation
Russian Federation
O. V. Tereshina
ГБОУ ВПО СамГМУ Минздравсоцразвития России
Russian Federation
Russian Federation
References
1. Guidelines for the management of atrial fibrillation // European Heart Journal. - 2010. - Vol. 31. - P. 2369-2429.
2. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation // Europace. - 2006. -№8. - P. 651-745.
3. Панченко Е.П. Профилактика тромбоэмболий у больных мерцательной аритмией / Е.П.Панченко, Е.С.Кропачева. - М.: OOO «Медицинское информационное агентство», 2007. - 144 с.
4. Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis / L.Sanglas [et al.] // Molecular Cell. - 2008. - № 4. - P. 598-606.
5. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis / P.Miljic [et al.] // Srp. Arh. Celok. Lek. - 2010. Vol. 138. - Suppl 1. - P. 74-78.
6. TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays / V.Schroeder [et al.] // Thromb. Haemost. - 2006. - № 2. - P. 236-237.
7. Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men / M.E.Meltzer [et al.] // Haematologica. - 2009. № 6. P. 811-818.
8. Ilhan D. Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke / D.Ilhan, D.Ozbabalik, E.Gulcan // Neurologist. - 2010. - №3. - P. 188-191.
9. Meltzer M.E. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 / M.E.Meltzer, T.Lisman, P.G. de Groot // Blood. - 2010. - №1. - P. 113-121.
10. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection) / Y.Wang [et al.] // Circulation. - 2006. - Vol. 113. - № 12. - P. 1615 - 1621.
11. Common VKORC1 variants are not associated with arterial or venous thrombosis / L.A.Hindorff [et al.] // J Thromb Haemost. - 2007. - №5. - P. 2025-2027.
12. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers / J.Montaner [et al.] // Stroke. - 2008. - № 8. - P. 2280 - 2287.
13. Watson, T. Fibrin D-dimer levels and thromboembolic events in patients with atrial fibrillation / T. Watson, E.Shantsila, GY.Lip // Int J Cardiol. - 2007. - № 9. - P. 123124
14. Echocardiographic predictors of left atrial appendage thrombus formation / S.Ayirala [et al.] // J Am Soc Echocardiogr. - 2011. - Vol. 24. - № 5. - P. 499-505.
15. VKORC1 genetic polymorphism and risk of venous thromboembolism in postmenopausal women: new findings and meta-analysis / C.Verstuyft [et al.] // J Thromb Haemost. - 2009. -Vol. 7. - № 6. - P. 1034-1036.
16. No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease / DM.Smadja [et al.] // Thromb Haemost. - 2008. - Vol. 99. - № 5. - P. 970 - 972.
17. Zabalgoitia M. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in non-valvular atrial fibrillation / M.Zabalgoitia, J.L.Halperin, L.A.Pearce // J Am Coll Cardiol. - 1998. - Vol. 31. - P. 1622-1626
18. Сердечная Е.В. Дополнительные маркеры риска тромбоэмболического инсульта у больных с фибрилляцией предсердий / Е.В.Сердечная, Т.А.Истомина, Л.А.Кульминская // Экология человека. - 2006. - №19. - С 3742.
19. Pullicino P.M. Stroke in patients with heart failure and reduced left ventricular ejection fraction / P.M.Pullicino, J.L.Halperin, J.L.P.Thompson // Neurology. - 2000. - Vol. 54. -№ 2. - C. 288.
Review
For citations:
Shchukin Yu.V., Rubanenko A.O., Germanov A.V., Tereshina O.V. RISK FACTORS OF ISCHEMIC STROKE IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION. Journal of Arrhythmology. 2012;67(67):20-25. (In Russ.)
Views:
457
Email this article 